MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.780
+0.050 (2.89%)
Jul 10, 2026, 4:00 PM EDT - Market closed
MetaVia Employees
MetaVia had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,640,625
Market Cap
9.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Dec 31, 2024 | 9 | 1 | 12.50% |
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | -3 | -60.00% |
| Dec 31, 2021 | 5 | -2 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Curis | 24 |
| Imunon | 20 |
| BioRestorative Therapies | 14 |
| TransCode Therapeutics | 12 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Quoin Pharmaceuticals | 6 |
| Cadrenal Therapeutics | 5 |
MTVA News
- 2 days ago - MetaVia announces completion of dose titration in Phase 1 study of DA-1726 - TheFly
- 2 days ago - MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity - PRNewsWire
- 16 days ago - MetaVia Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 24 days ago - MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum - PRNewsWire
- 4 weeks ago - MetaVia Transcript: Emerging Growth Conference 93 - Transcripts
- 4 weeks ago - MetaVia Transcript: AGM 2026 - Transcripts
- 4 weeks ago - MetaVia presents data at ADA supporting DA-1726, vanoglipel - TheFly
- 4 weeks ago - MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential - PRNewsWire